| | | 68752 | | 14.02.2023 | | MSD Merck Sharp & Dohme AG | | | | | | | 13.02.2028 | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Vaxneuvance | Injektionssuspension | Injection suspension ( 2µg / 0.5ml, 4µg / 0.5ml, 2µg / 0.5ml, 2µg / 0.5ml, 2µg / 0.5ml, 2µg / 0.5ml, 2µg / 0.5ml, 2µg / 0.5ml, 2µg / 0.5ml, 2µg / 0.5ml) | J07AL02 | |
|
|
